The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
124837943 12483794 3 F 20141117 20160704 20160621 20160712 EXP PHHY2016DE061178 NOVARTIS 0.00 A M Y 0.00000 20160712 OT DE DE

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
124837943 12483794 1 PS AFINITOR EVEROLIMUS 1 Oral 10 MG, QD (1-0-0) 22334 10 MG QD
124837943 12483794 2 SS AFINITOR EVEROLIMUS 1 Oral 5 MG, QD 22334 5 MG QD
124837943 12483794 3 SS AFINITOR EVEROLIMUS 1 Oral 10 MG, QD 22334 10 MG QD
124837943 12483794 4 SS VOTRIENT PAZOPANIB HYDROCHLORIDE 1 Oral 400 MG, BID 0 400 MG BID
124837943 12483794 5 SS VOTRIENT PAZOPANIB HYDROCHLORIDE 1 Oral 200 MG, BID 0 200 MG BID
124837943 12483794 6 SS VOTRIENT PAZOPANIB HYDROCHLORIDE 1 Oral 400 MG, BID 0 400 MG BID
124837943 12483794 7 C CALCIUM CALCIUM 1 Unknown 500 MG, BID (1-0-1) 0 500 MG BID
124837943 12483794 8 C XGEVA DENOSUMAB 1 Subcutaneous 120 MG, (EVERY 4 WEEKS) 0 120 MG
124837943 12483794 9 C GABAPENTIN. GABAPENTIN 1 Unknown 300 MG, QD (FIRST DAY) 0 300 MG QD
124837943 12483794 10 C GABAPENTIN. GABAPENTIN 1 Unknown 300 MG, BID (2ND DAY BID) 0 300 MG BID
124837943 12483794 11 C DEXAMETHASON DEXAMETHASONE 1 Unknown 4 MG, BID 0 4 MG BID
124837943 12483794 12 C PANTOZOL PANTOPRAZOLE SODIUM 1 Unknown 40 MG, BID (1-0-0) 0 40 MG BID
124837943 12483794 13 C MOVICOL POLYETHYLENE GLYCOL 3350POTASSIUM CHLORIDESODIUM BICARBONATESODIUM CHLORIDE 1 Oral 1 DF, QD (1 TABLESPOON 1-0-0) 0 1 DF QD
124837943 12483794 14 C TILIDIN COMP NALOXONE HYDROCHLORIDETILIDINE HYDROCHLORIDE 1 Unknown 100/8 OT (1-0-1) 0 BID
124837943 12483794 15 C TILIDIN COMP NALOXONE HYDROCHLORIDETILIDINE HYDROCHLORIDE 1 Unknown 50/4 OT (1-0-1) 0 BID
124837943 12483794 16 C INLYTA AXITINIB 1 Unknown 5 MG, BID (1-0-1) 0 5 MG BID
124837943 12483794 17 C LYRICA PREGABALIN 1 Unknown 200 MG, (50-0-0- 150 MG) 0 200 MG
124837943 12483794 18 C TRANXILIUM CLORAZEPATE DIPOTASSIUM 1 Unknown 10 MG, UNK (FOR SEDATION AT NIGHT)) 0 10 MG
124837943 12483794 19 C MAGNESIUM VERLA//MAGNESIUM ASPARTATE 2 Unknown UNK UNK, BID (1-0-1) 0 BID
124837943 12483794 20 C METOPROLOL. METOPROLOL 1 Unknown 25 MG, QD (1-0-0) 0 25 MG QD
124837943 12483794 21 C LASIX FUROSEMIDE 1 Unknown 40 MG, QD (1-0-0) 0 40 MG QD
124837943 12483794 22 C TARGIN NALOXONE HYDROCHLORIDEOXYCODONE HYDROCHLORIDE 1 Unknown 20 MG, BID (1-0-1) 0 20 MG BID
124837943 12483794 23 C VITAMINA D 2 Unknown 500 MG, BID (1-0-1) 0 500 MG BID

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
124837943 12483794 1 Metastatic renal cell carcinoma
124837943 12483794 4 Renal cell carcinoma
124837943 12483794 7 Product used for unknown indication
124837943 12483794 8 Product used for unknown indication
124837943 12483794 9 Product used for unknown indication
124837943 12483794 11 Product used for unknown indication
124837943 12483794 12 Product used for unknown indication
124837943 12483794 13 Product used for unknown indication
124837943 12483794 14 Product used for unknown indication
124837943 12483794 16 Product used for unknown indication
124837943 12483794 17 Product used for unknown indication
124837943 12483794 18 Sedation
124837943 12483794 19 Product used for unknown indication
124837943 12483794 20 Product used for unknown indication
124837943 12483794 21 Product used for unknown indication
124837943 12483794 22 Product used for unknown indication
124837943 12483794 23 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
124837943 12483794 DE
124837943 12483794 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
124837943 12483794 Abdominal pain upper
124837943 12483794 Cholestasis
124837943 12483794 General physical health deterioration
124837943 12483794 Haemoglobin decreased
124837943 12483794 Malignant neoplasm progression

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
124837943 12483794 1 20150217 20150310 0
124837943 12483794 2 20150311 20150318 0
124837943 12483794 3 20150319 20150629 0
124837943 12483794 4 20140821 20140930 0
124837943 12483794 5 20140930 20141021 0
124837943 12483794 6 20141022 20141112 0
124837943 12483794 7 20140902 0
124837943 12483794 8 20140902 20141028 0
124837943 12483794 11 201408 0
124837943 12483794 12 20141021 0
124837943 12483794 13 20150302 0
124837943 12483794 14 20150322 0
124837943 12483794 15 20150322 0
124837943 12483794 16 20150630 20150930 0
124837943 12483794 17 20150504 0
124837943 12483794 18 20150504 0
124837943 12483794 19 20150504 0
124837943 12483794 20 20150628 0
124837943 12483794 21 20150911 20150917 0
124837943 12483794 22 20150504 0
124837943 12483794 23 20140902 0